Literature DB >> 27795426

The Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells.

Lindsey M Hutt-Fletcher1.   

Abstract

The roles of epithelial cells in infection and persistence of the Epstein-Barr virus (EBV) have long been difficult to resolve. However, recent developments have reinforced the conclusion that these cells are a major site of virus replication and raised the possibility that, like papillomaviruses, EBV has evolved to take advantage of epithelial differentiation to ensure survival, persistence, and spread.
Copyright © 2016 American Society for Microbiology.

Entities:  

Keywords:  Epstein-Barr virus; epithelial cells; tropism

Mesh:

Substances:

Year:  2016        PMID: 27795426      PMCID: PMC5165189          DOI: 10.1128/JVI.01677-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya.

Authors:  C Desgranges; H Wolf; G De-Thé; K Shanmugaratnam; N Cammoun; R Ellouz; G Klein; K Lennert; N Muñoz; H Zur Hausen
Journal:  Int J Cancer       Date:  1975-07-15       Impact factor: 7.396

Review 2.  Epstein-Barr virus entry.

Authors:  Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

3.  Replication of EBV in epithelial cells during infectious mononucleosis.

Authors:  S M Lemon; L M Hutt; J E Shaw; J L Li; J S Pagano
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

Review 4.  Epstein-Barr virus and the B cell: that's all it takes.

Authors:  D A Thorley-Lawson; E M Miyashita; G Khan
Journal:  Trends Microbiol       Date:  1996-05       Impact factor: 17.079

5.  Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion.

Authors:  J S Greenspan; D Greenspan; E T Lennette; D I Abrams; M A Conant; V Petersen; U K Freese
Journal:  N Engl J Med       Date:  1985-12-19       Impact factor: 91.245

6.  Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase.

Authors:  G Niedobitek; L S Young; R Lau; L Brooks; D Greenspan; J S Greenspan; A B Rickinson
Journal:  J Gen Virol       Date:  1991-12       Impact factor: 3.891

7.  Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells.

Authors:  Chi Man Tsang; Yim Ling Yip; Kwok Wai Lo; Wen Deng; Ka Fai To; Pok Man Hau; Victoria Ming Yi Lau; Kenzo Takada; Vivian Wai Yan Lui; Maria Li Lung; Honglin Chen; Musheng Zeng; Jaap Michiel Middeldorp; Annie Lai-Man Cheung; Sai Wah Tsao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-16       Impact factor: 11.205

8.  Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.

Authors:  Q Li; M K Spriggs; S Kovats; S M Turk; M R Comeau; B Nepom; L M Hutt-Fletcher
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

9.  Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells.

Authors:  C D Shannon-Lowe; B Neuhierl; G Baldwin; A B Rickinson; H-J Delecluse
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-10       Impact factor: 11.205

10.  The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output.

Authors:  Vey Hadinoto; Michael Shapiro; Chia Chi Sun; David A Thorley-Lawson
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

View more
  27 in total

1.  Murine Cytomegalovirus Glycoprotein O Promotes Epithelial Cell Infection In Vivo.

Authors:  Joseph Yunis; Helen E Farrell; Kimberley Bruce; Clara Lawler; Orry Wyer; Nicholas Davis-Poynter; Ilija Brizić; Stipan Jonjić; Barbara Adler; Philip G Stevenson
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

2.  Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication.

Authors:  Wenmin Fu; Dinesh Verma; Ashlee Burton; Sankar Swaminathan
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

3.  Early Epstein-Barr Virus Genomic Diversity and Convergence toward the B95.8 Genome in Primary Infection.

Authors:  Eric R Weiss; Susanna L Lamers; Jennifer L Henderson; Alexandre Melnikov; Mohan Somasundaran; Manuel Garber; Liisa Selin; Chad Nusbaum; Katherine Luzuriaga
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

4.  Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters.

Authors:  Dinesh Verma; Trenton Mel Church; Sankar Swaminathan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-20       Impact factor: 11.205

5.  A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo.

Authors:  Junping Hong; Ling Zhong; Qingbing Zheng; Qian Wu; Zhenghui Zha; Dongmei Wei; Haiwen Chen; Wanlin Zhang; Shanshan Zhang; Yang Huang; Kaiyun Chen; Junyu Chen; Shaowei Li; Mu-Sheng Zeng; Yi-Xin Zeng; Ningshao Xia; Xiao Zhang; Miao Xu; Yixin Chen
Journal:  J Virol       Date:  2022-03-29       Impact factor: 6.549

6.  A primary nasopharyngeal three-dimensional air-liquid interface cell culture model of the pseudostratified epithelium reveals differential donor- and cell type-specific susceptibility to Epstein-Barr virus infection.

Authors:  Phillip Ziegler; Yarong Tian; Yulong Bai; Sanna Abrahamsson; Alan Bäckerholm; Alex S Reznik; Anthony Green; John A Moore; Stella E Lee; Michael M Myerburg; Hyun Jung Park; Ka-Wei Tang; Kathy Ho Yen Shair
Journal:  PLoS Pathog       Date:  2021-04-29       Impact factor: 6.823

7.  No evidence for the presence of Epstein-Barr virus in squamous cell carcinoma of the mobile tongue.

Authors:  Torben Wilms; Gulfaraz Khan; Philip J Coates; Nicola Sgaramella; Robin Fåhraeus; Asma Hassani; Pretty S Philip; Lena Norberg Spaak; Luigi Califano; Giuseppe Colella; Katarina Olofsson; Christos Loizou; Renato Franco; Karin Nylander
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

Review 8.  Epstein-Barr Virus-Specific Immune Control by Innate Lymphocytes.

Authors:  Christian Münz
Journal:  Front Immunol       Date:  2017-11-24       Impact factor: 7.561

Review 9.  Human immunity against EBV-lessons from the clinic.

Authors:  Stuart G Tangye; Umaimainthan Palendira; Emily S J Edwards
Journal:  J Exp Med       Date:  2017-01-20       Impact factor: 14.307

Review 10.  Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer.

Authors:  Ramon Yarza; Mateo Bover; Maria Teresa Agulló-Ortuño; Lara Carmen Iglesias-Docampo
Journal:  J Exp Clin Cancer Res       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.